Resolution of amisulpride-associated amenorrhea by switching to aripiprazole

Bun Hee Lee, Yong Ku Kim

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: To report a 4-case series in which amisulpride-induced symptomatic hyperprolactinemia was resolved by switching to aripiprazole. Case Reports: Four female patients developed symptomatic hyperprolactinemia such as amenorrhea and/or galactorrhea with elevated serum prolactin levels (113.7-230.0 ng/mL) after taking amisulpride (200-800 mg/day). To resolve the problem of symptomatic hyperprolactinemia, reducing the dosage of amisulpride was first tried, however this approach turned out to have no effect. Subsequently, all 4 patients were switched from amisulpride to aripiprazole (10-20 mg/day), upon which their regular menstrual cycles returned and galactorrhea improved, with the normalization of their serum prolactin levels (6.5-15.0 ng/mL) within 4 weeks after switching. Conclusion: Switching to aripiprazole, a partial dopamine agonist, is an effective strategy for the resolution of antipsychotic-induced hyperprolactinemia and associated adverse effects.

Original languageEnglish
Pages (from-to)102-106
Number of pages5
JournalPsychiatry Investigation
Volume3
Issue number1
Publication statusPublished - 2006 Feb 1

Fingerprint

Hyperprolactinemia
Amenorrhea
Galactorrhea
Prolactin
Dopamine Agonists
Menstrual Cycle
Serum
Antipsychotic Agents
Aripiprazole
sultopride

Keywords

  • Amenorrhea
  • Amisulpride
  • Aripiprazole
  • Galactorrhea
  • Prolactin

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Resolution of amisulpride-associated amenorrhea by switching to aripiprazole. / Lee, Bun Hee; Kim, Yong Ku.

In: Psychiatry Investigation, Vol. 3, No. 1, 01.02.2006, p. 102-106.

Research output: Contribution to journalArticle

@article{c7224ef173f7498e95735d031ace1365,
title = "Resolution of amisulpride-associated amenorrhea by switching to aripiprazole",
abstract = "Objective: To report a 4-case series in which amisulpride-induced symptomatic hyperprolactinemia was resolved by switching to aripiprazole. Case Reports: Four female patients developed symptomatic hyperprolactinemia such as amenorrhea and/or galactorrhea with elevated serum prolactin levels (113.7-230.0 ng/mL) after taking amisulpride (200-800 mg/day). To resolve the problem of symptomatic hyperprolactinemia, reducing the dosage of amisulpride was first tried, however this approach turned out to have no effect. Subsequently, all 4 patients were switched from amisulpride to aripiprazole (10-20 mg/day), upon which their regular menstrual cycles returned and galactorrhea improved, with the normalization of their serum prolactin levels (6.5-15.0 ng/mL) within 4 weeks after switching. Conclusion: Switching to aripiprazole, a partial dopamine agonist, is an effective strategy for the resolution of antipsychotic-induced hyperprolactinemia and associated adverse effects.",
keywords = "Amenorrhea, Amisulpride, Aripiprazole, Galactorrhea, Prolactin",
author = "Lee, {Bun Hee} and Kim, {Yong Ku}",
year = "2006",
month = "2",
day = "1",
language = "English",
volume = "3",
pages = "102--106",
journal = "Psychiatry Investigation",
issn = "1738-3684",
publisher = "Korean Neuropsychiatric Association",
number = "1",

}

TY - JOUR

T1 - Resolution of amisulpride-associated amenorrhea by switching to aripiprazole

AU - Lee, Bun Hee

AU - Kim, Yong Ku

PY - 2006/2/1

Y1 - 2006/2/1

N2 - Objective: To report a 4-case series in which amisulpride-induced symptomatic hyperprolactinemia was resolved by switching to aripiprazole. Case Reports: Four female patients developed symptomatic hyperprolactinemia such as amenorrhea and/or galactorrhea with elevated serum prolactin levels (113.7-230.0 ng/mL) after taking amisulpride (200-800 mg/day). To resolve the problem of symptomatic hyperprolactinemia, reducing the dosage of amisulpride was first tried, however this approach turned out to have no effect. Subsequently, all 4 patients were switched from amisulpride to aripiprazole (10-20 mg/day), upon which their regular menstrual cycles returned and galactorrhea improved, with the normalization of their serum prolactin levels (6.5-15.0 ng/mL) within 4 weeks after switching. Conclusion: Switching to aripiprazole, a partial dopamine agonist, is an effective strategy for the resolution of antipsychotic-induced hyperprolactinemia and associated adverse effects.

AB - Objective: To report a 4-case series in which amisulpride-induced symptomatic hyperprolactinemia was resolved by switching to aripiprazole. Case Reports: Four female patients developed symptomatic hyperprolactinemia such as amenorrhea and/or galactorrhea with elevated serum prolactin levels (113.7-230.0 ng/mL) after taking amisulpride (200-800 mg/day). To resolve the problem of symptomatic hyperprolactinemia, reducing the dosage of amisulpride was first tried, however this approach turned out to have no effect. Subsequently, all 4 patients were switched from amisulpride to aripiprazole (10-20 mg/day), upon which their regular menstrual cycles returned and galactorrhea improved, with the normalization of their serum prolactin levels (6.5-15.0 ng/mL) within 4 weeks after switching. Conclusion: Switching to aripiprazole, a partial dopamine agonist, is an effective strategy for the resolution of antipsychotic-induced hyperprolactinemia and associated adverse effects.

KW - Amenorrhea

KW - Amisulpride

KW - Aripiprazole

KW - Galactorrhea

KW - Prolactin

UR - http://www.scopus.com/inward/record.url?scp=33645675095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645675095&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33645675095

VL - 3

SP - 102

EP - 106

JO - Psychiatry Investigation

JF - Psychiatry Investigation

SN - 1738-3684

IS - 1

ER -